Vertiflex® Spinal Stenosis Treatment in the Antelope Valley, California

AVORS Medical Group • March 30, 2021

 A Minimally Invasive Implant Procedure in Lancaster, California.


AVORS Medical Group understands that our community contains several patients who suffer from mild to moderate Spinal Stenosis.  Spinal stenosis is a common cause of back pain. This condition causes the canal inside the spinal cord to narrow and pinch the spinal nerves. This can cause pains in the neck and back as well as radiating pain in the arms and legs. The more the spinal canal narrows, the more damage it does to the nerves.

The most common symptoms of spinal stenosis can include:
  • Back and neck pain
  • Pain while walking
  • Difficulty performing physical activity for extended periods
  • Weakness and/or loss of balance
  • Pain reduces when sitting or lying down
  • Numb feeling in the legs, calves, or buttocks
  • Radiating pain in the legs
  • Decreased endurance to physical activities or even walking
AVORS Medical Group can use the Vertiflex® implant to treat spinal stenosis for eligible patients. Unlike some implant procedures, the Vertiflex surgery is minimally invasive and can be done on an outpatient basis.

About the Vertiflex Procedure:
The Vertiflex implant is a small device made of titanium that can widen the spinal canal. Titanium is a lightweight, durable material that is biocompatible, meaning there is less risk that its introduction to the spine will cause an inflammatory reaction.

During the implant procedure, a small incision is made in the lower back. The Vertiflex implant is then placed between the vertebrae, holding them open and reducing pressure on the spinal canal. This operation causes little bleeding and should not damage bone or tissue. The entire procedure takes around 20 minutes. You should be prepared to limit your activities over the next few days as you let your body heal.

Who Should Receive a Vertiflex Implant?
The Vertiflex implant procedure is ideal for patients with mild to moderate spinal stenosis. Because it is minimally invasive, it is often recommended for patients who would have a difficult time with a more involved back surgery.

How Effective is the Treatment:
Based on a study published in the Journal of Pain Research in November 2018, the researchers examined and characterized the opioid medication usage patterns among patients treated with stand-alone IPD through 5 years of postoperative follow-up. The primary analysis included all 190 patients randomized to receive the Superion® device. In a sub-group of 98 subjects, they determined opioid medication prevalence among subjects with a prior history of opioid use. The results indicated that between baseline and 5 years, there was an 85% decrease in the proportion of subjects using opioids, and a decreased opioid medication usage was also observed among the sub-group of subjects with a history of opiates prior to entering the trial.

How do I schedule with an AVORS Interventional Pain Management?
If you’re suffering from spinal stenosis, find out if you’re a candidate for the Superion InterSpinous Spacer by calling 661-726-5005 to schedule an appointment. Ask to schedule a consultation with Dr. Thomas Nasser, D.O.  

If you would like to learn more about this procedure, click on the following link below

To learn more about Dr. Thomas Nasser, D.O. click on the following link below

References: 

Patel V, Nunley P, Whang P, et al. Superion® interspinous spacer for treatment of moderate degenerative lumbar spinal stenosis: durable three-year results of a randomized controlled trial, Journal of Pain Research. 2105;8:657-662.
Patel V, Whang P, Haley T, et al. Superion Interspinous Process Spacer for Intermittent Neurogenic Claudication Secondary to Moderate Lumbar Spinal Stenosis: Two-year results from a randomized controlled FDA-IDE pivotal trial. Spine. 2015;40(5):275-282.
Lauryseen C, Jackson R, Baron J. Stand-alone interspinous spacer versus decompressive laminectomy for treatment of lumbar spinal stenosis. Expert Rev Med Devices. 2015 [early online].
Loguidice V, Bini W, Shabat S, et al. Rationale,design and clinical performance of the Superion® Interspinous Spacer: a minimally invasive implant for treatment of lumbar spinal stenosis. Expert Rev Med Devices. 2011;8(4):419–426.

 
Platelet-Rich Plasma
By Joseph Hurley • October 1, 2026
Sidelined by an injury? Platelet-Rich Plasma therapy at AVORS Medical Group helps Antelope Valley athletes heal fast without surgery. Book today!
September 24, 2026
Dr. Scott Daniel, DO, has been named AV's Best Pain Management Provider. Learn how AVORS Medical Group's unique approach to pain management, PM&R, and musculoskeletal care is improving patient outcomes throughout the Antelope Valley.
Tennis Elbow
By Joseph Hurley • September 24, 2026
Discover effective tennis elbow treatment and care options. Explore proven non-surgical therapies and surgical care with AVORS Medical Group specialists.
September 21, 2026
AVORS Medical Group Named AV's Best Medical Group 2026 in Lancaster and Palmdale, California. Schedule a call at 661-726-5005 with our award winning clinic.
Hip Replacement
By Joseph Hurley • September 17, 2026
Suffer from severe hip pain? AVORS Medical Group offers anterior total hip replacement in Lancaster, Sylmar & Valencia. Schedule your evaluation today!
September 11, 2026
Dr. Kofi Agyeman Named and Awarded AV’s Best 2026 – Best Orthopedic Surgeon in the Antelope Valley. Call to schedule a consultation of 661-726-5005 to schedule an appointment.
September 10, 2026
Dr. Sarah Gostich of AVORS Medical Group, voted winner of AV’s Best Podiatrist 2026, provides advanced foot and ankle care and total ankle replacement in Lancaster, CA.
September 10, 2026
AVORS Medical Group Recognized as a Finalist for Community Clinic of the Year 2026 by the Los Angeles Business Journal. Call us at 661-726-5005 to schedule an appointment.
Carpal Tunnel Treatment
By Joseph Hurley • September 10, 2026
Get carpal tunnel relief in Lancaster, Palmdale & Sylmar. From conservative tips to endoscopic release with Dr. Heller. Book your AVORS consult.
September 8, 2026
Joseph Hurley, CEO of AVORS Medical Group, nominated and Finalist with the Los Angeles Business Journal, Health Systems Executive of the Year for 2026.